Race and survival from breast cancer: Based on cancer and leukemia group B trial 8541

Cancer Journal from Scientific American

Volumn 3, Issue 2, 1997, Pages 107-112

  Roach III, Mack ^a,g   Cirrincione, Constance ^b   Budman, Daniel ^c   Hayes, Daniel ^d   Berry, Don ^b   Younger, Jerry ^e   Hart, Ronald ^f   Henderson, I Craig ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cancer and Leukemia Group B Statistical Center   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f ST LUKE S MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adjuvant chemotherapy and race; African Americans and cancer; breast cancer and race; Race and cancer

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; SURVIVAL TIME; TREATMENT OUTCOME;

AFRICAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; NEOPLASM STAGING; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 0030906480     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Cancer Statistics Review: 1973-1986. Bethesda, MD: National Cancer Institute, 1989. NIH publication 90-2789.
2. Satariano WA, Belle SH, Swanson GM. The severity of breast cancer at diagnosis: a comparison of age and extent of disease in black and white women. Am J Public Health 1986;76:779-782.
3. Roach M, Alexander M. The prognostic significance of race and survival from breast cancer. J Natl Med Assoc 1995;87:3.
4. Siegel R, Arena C, Blacklow B et al. Survival of black women with stage I and stage II breast cancer is inferior to the survival among white women treated in the same way at a single institution. J Clin Oncol 1994;13:68.
5. Muss H, Wesley M, Chen V et al. Estrogen receptor (ER) and progesterone receptor (PR) are related to survival in black and white women with breast cancer (BC): The National Cancer Institute (NCI) Black/White Cancer Survival Study experience. J Clin Oncol 1994;13:79.
6. Bassett MT, Krieger NK. Social class and black-white differences in breast cancer survival. Am J Public Health 1986;76:1400-1403.
7. Dayal H, Power R, Chui C. Race and socio-economic status in survival from breast cancer. Journal of Chronic Diseases 1982;27: 675-683.
8. Keim W, Metter G. Survival of cancer patients by economic status in a free care setting. Cancer 1985;55:1552-1555.
9. Diehr P, Yergan J, Chu J et al. Treatment modality and quality differences for black and white breast cancer patients treated in community hospitals. Med Care 1989;27:942-958.
10. Egbert LD, Rothman IL. Relationship between race and economic status of patients and who performs their surgery. N Engl J Med 1977;297:90-91.
11. Flaherty JA Meagher R Measuring racial bias in inpatient treatment. Am J Psychiatry 1980;137:679-682.
12. McWhorter WP, Mayer WJ. Black-white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health 1987;77:1515-1517.
13. Wood WC, Budman DR, Korzun AH et al. Dose and dose intensity of adjuvant chemotherapy for stage II node positive breast cancer. N Engl J Med 1994;330:1253-1259.
14. Albain KS, Green S, LeBlanc M et al. Proportional hazards and recursive partitioning and amalgamation analyses of Southwest Oncology node-positive adjuvant CMFVP breast cancer data base: a pilot study. Breast Cancer Res Treat 1992;22:273-284.
15. Axtell LM, Myers MH. Contrasts in survival of black and white cancer patients, 1960-73. J Natl Cancer Inst 1978;60:1209-1215.
16. Mittra NK, Rush BF, Verner E. A comparative study of breast cancer in the black and white populations of two inner-city hospitals. J Surg Oncol 1980;15:11-17.
17. Dayal HH, Power RN, Chiu C. Race and socio-economic status in survival from breast cancer. Journal of Chronic Diseases 1982; 35:675-683.
18. Shapiro S, Venet W, Strax P et al. Prospects for eliminating racial differences in breast cancer survival rates. Am J Public Health 1982; 72:1142-1154.
19. Gregorio DI, Cummings KM, Michalek A. Delay, stage of disease, and survival among white and black women with breast cancer. Am J Public Health 1983;73:590-593.
20. Natarajan N, Nemoto T, Mettlin C et al. Race-related differences in breast cancer patients: results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer 1985; 56:1704-1709.
21. Bain RP, Greenberg RS, Whitaker JP. Racial differences in survival of women with breast cancer. Journal of Chronic Diseases 1986;39:631-642.
22. Crowe JP, Gordon NH, Hubay CA et al. The interaction of estrogen receptor status and race in predicting prognosis for stage I breast cancer patients. Surgery 1986;100:599-605.
23. Valanis B, Wirman J, Hertzberg VS. Social and biological factors in relation to survival among black vs. white women with breast cancer. Breast Cancer Res Treat 1987;9:135-144.
24. Polednak AP. A comparison of survival of black and white female breast cancer cases in upstate New York. Cancer Detect Prev 1988;11:245-249.
25. Dansey RD, Hessel PA, Browde S et al. Lack of a significant independent effect of race on survival in breast cancer. Cancer 1988; 61:1908-1912.
26. Sutherland CM, Mather FJ. Charity hospital experience with long-term survival and prognostic factors in patients with breast cancer with localized or regional disease. Ann Surg 1988;207:569-580.
27. Vaughn CB, Chapman JL, Gertz K et al. Biological behavior of breast cancer in blacks and whites [abstract]. Proc ASCO 1988;7:31.
28. Fields JN, Kuske RR, Perez CA et al. Prognostic factors in inflammatory breast cancer. Cancer 1989;63:1225-1232.
29. Fisher ER, Redmond C, Fisher B et al. Pathologic discriminants for 8-year survival for node-negative invasive breast cancer patients. Cancer 1990;65:2121-2128.
30. Coates RJ, Clark WS, Eley JW et al. Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst 1990;82:1684-1692.
31. Cella DF, Orav EJ, Kornblith AB et al. Socioeconomic status and cancer survival. J Clin Oncol 1991;9:1500-1509.
32. Fisher B, Anderson S, Fisher ER et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991;338: 327-333.
33. Elledge RM, Clark GM, Chamness GC et al. Tumor biologic factors and breast cancer prognosis among white, hispanic, and black women in the United States. J Natl Cancer Inst 1994;86:705-712.
34. Nattinger AB, Gottlieb MS, Veum BS et al. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 1992;326:1102-1107.
35. Farrow DC, Hunt XX, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992;326: 1097-1101.
36. Fisher B, Constantino J, Wickerham L et al. Treatment of intraductal breast cancer (DCIS): results of NSABP B-17 [abstract]. Proc ASCO 1993;12:70.
37. Pierce SM, Schnitt S, Gelman R et al. Excision without radiation therapy in selected patients with early stage breast cancer [abstract]. Proc ASCO 1993;12:70.
38. Ragaz J, Jackson SM, Plenderleith IH et al. Can adjuvant radiotherapy (XRT) improve the overall survival (OS) of breast cancer (BR CA) patients in the presence of adjuvant chemotherapy (CT)? 10 year analysis of the British Columbia Randomized Trial [abstract]. Proc ASCO 1993;12:70.
39. Eley JW, Hill HA, Chen VW et al. Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 1994;272:947-954.
40. Roach M, Alexander M. The significance of race and time from symptom recognition to medical consultation for black and white women with breast cancer. Breast Diseases: A Year Book Quarterly 1993;4:22-23.
41. Krieger N. Exposure, susceptibility, and breast cancer risk. Breast Cancer Res Treat 1989;13:205-223.
42. Morabia A, Wynder EL. Epidemiology and natural history of breast cancer. Surg Clin North Am 1990;70:739-752.
43. Mandelblatt J, Andrews H, Kerner J et al. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health 1991;81:646-649.